Dr. Berenson is a Medical Expert Witness who is Board Certified in both Neurology and Pediatrics. He is located in Atlanta, GA. He states he has over 20 years of familiarity with phenobarbital and that he prescribes this drug to patients. He has completed two separate Fellowships in Pediatric Neurology. He is currently a Clinical Assistant Professor of Pediatrics at a university.
Furthermore, he has experience in Teaching Conferences too. Some of these are – Pediatrics Case Management conference: Myoglobinuria and CPT deficiency (August 23, 1994), Neurology resident and medical student conference: Peripheral Neuropathy and Leights Disease (May 9, 1995), Core Curriculum lecture series: “Status Emil epticus, evaluation and management” (July 27, 1995) and A Day of Rehabilitation (Seminar) at Children’s Healthcare of Atlanta “Meningitis & Encephalitis: New Facts & Outcomes” (October 2000).
Dr. Berenson has been the Principle Investigator for various Drug Trials. These include “An Open Label, Long Term Observational Study of Safety and Tolerability of Sumatriptan Nasal Spray in the Treatment of Migraine in Adolescents” – Protocol SUM 40276, Glaxo Wellcome, Inc. (2000-2001), “A Randomized, Open Label, Parallel-Groups, Outpatient Study to Examine the Long-Term Safety and Tolerability of Rizatriptan 5mg. P.O. for the Acute Treatment of Migraine in Adolescents” – Protocol MK-0462-061, MERCK Research Laboratories (2000-2001), “Randomized Double-Blind, Placebo-Controlled, Parallel Group, Single Attack Study to evaluate onset of Efficacy of a New Formulation of Sumatriptan Tablets (FDT) 50mg and 100mg in Acute Treatment of Migraine” – Protocol SUM 30047, GlaxoSmithKline (2003-2004) and “A Double-Blind, Multicenter, Randomized, Placebo-Controlled Study to evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches” – Protocol MT400-302, Pozen (2004-2005).
Dr. Berenson has also been a part of several abstract publications and presentations such as Focal Amyotrophy of Adolescence – American Academy of Electrophysiologic Medicine in Montreal, Canada (October 1995), Benign Myoclonus of Early Infancy: An Imitator of Infantile Spasms – Neurology 44 (Suppl. 2) p. A145 (April 1994) and Protean Clinical-EEG Manifestations of Temporal Lope Lesions in Infants – American Epilepsy Society (Dec. 1998).